Firsthand Technology Value Fund, Inc. (SVVC) BCG Matrix

Firsthand Technology Value Fund, Inc. (SVVC): BCG Matrix [Dec-2025 Updated]

US | Financial Services | Asset Management | NASDAQ
Firsthand Technology Value Fund, Inc. (SVVC) BCG Matrix

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Firsthand Technology Value Fund, Inc. (SVVC) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

Honestly, looking at Firsthand Technology Value Fund, Inc. (SVVC)'s portfolio through the BCG lens right now shows you exactly what a deeply distressed venture fund looks like, dominated by illiquid assets. By Q3 2025, the NAV had cratered to just $0.04 per share, driven by a net investment loss of $430,629, leaving the supposed 'Cash Cows' as a mere $59,009 in cash, so the stability is almost non-existent. The real question is whether the few remaining equity stakes-the potential Stars-can escape the gravitational pull of the Dogs; dig into the breakdown below to see which assets are truly worth tracking in this environment.



Background of Firsthand Technology Value Fund, Inc. (SVVC)

You're looking at Firsthand Technology Value Fund, Inc. (SVVC), which is a closed-end management investment company. Its main goal is to achieve long-term growth of capital, mostly by trying to get capital gains from its investments in equity and related securities. The Fund's portfolio is heavily weighted toward equity and equity derivative securities of illiquid private technology and cleantech companies, though it can also buy micro-cap public companies with market caps under 250 million dollars.

The advisory services for SVVC are provided by Firsthand Funds LLC, which has specialized expertise in these emerging technology and life science markets. Kevin Landis serves as the Chief Executive Officer and Chief Financial Officer for Firsthand Technology Value Fund Inc. The structure itself is externally managed and non-diversified, and it actually converted into a business development company, or BDC, back in 2011, which increased its exposure to private equity.

Honestly, the recent performance has been tough, which is probably why you're digging into the portfolio now. For the third quarter of 2025, which ended on November 14, 2025, the reported net asset value (NAV) per share was just $0.04. This followed a Q2 2025 NAV of $0.11 per share as of June 30, 2025, when net assets stood at $0.7 million.

Looking at the very latest figures from Q3 2025, the net assets had shrunk further to $296,547, and the fund reported a net investment loss of $430,629 for that quarter alone. To give you some context on the stock trading side, as of November 25, 2025, the closing price was $0.100, with a 52-week range between $0.03 and $0.09, and a market capitalization of approximately $342,584.88. The fund's historical struggles are defintely well-documented, with shareholders pushing for liquidation for years due to significant NAV collapse since 2020.



Firsthand Technology Value Fund, Inc. (SVVC) - BCG Matrix: Stars

You're looking at the Firsthand Technology Value Fund, Inc. (SVVC) portfolio, trying to spot the assets that are leading their respective markets, the ones that should be generating serious returns. In the BCG framework, Stars are those holdings in high-growth sectors that command a strong market share; they need cash to fuel that growth, but they are the future Cash Cows.

For Firsthand Technology Value Fund, Inc., the conceptual Stars are rooted in its core thesis: remaining equity in high-growth sectors like cleantech and medtech. These are the areas where the Fund believes market expansion will be strongest, even if the current valuation of the entire fund is compressed. Honestly, the fund's strategy hinges on these select investments performing well enough to overcome the broader portfolio challenges.

The largest private holding, such as IntraOp Medical Corp., represents the type of asset that would typically fall into this category, being a leader in its niche medical device space. While the most recent specific weighting available shows it at 45.4% of Net Assets as of June 30, 2023, it remains a key focus for management seeking to enhance performance and uncover exit opportunities. The Mobetron device, for instance, is noted for being the only one of its kind usable in the operating room itself, which speaks to a potential market leadership position.

A key metric for identifying assets that are currently outperforming the general portfolio trend is examining those that avoided the recent negative performance. For the quarter ended September 30, 2025, the Fund reported net realized and unrealized losses on investments totaling $20,083. Any holding that did not contribute to this figure, or better yet, saw a positive mark-to-market adjustment, would be a candidate for a Star designation, or at least a strong Question Mark.

The challenge for these potential Stars is that they exist within a fund with a very low current valuation. As of September 30, 2025, the net assets stood at $296,547, or $0.04 per share, down from approximately $0.7 million, or $0.11 per share, on June 30, 2025. Still, these assets are what management is focused on growing, as they are the ones that could command a high valuation in a strategic acquisition, despite the Fund's low Net Asset Value (NAV).

Here's a quick look at the financial context surrounding these investments as of the third quarter of 2025:

Metric Value as of 9/30/2025 Value as of 6/30/2025
Net Assets $296,547 Approx. $0.7 million
NAV Per Share $0.04 $0.11
Total Shares Outstanding 6,893,056 Not specified
Net Realized/Unrealized Investment Loss (Q3 2025) $20,083 N/A
Equity/Debt Investments Value $197,925 N/A

The assets that fit the Star profile are those private technology and cleantech companies where the Fund sees sustained growth potential. These are the investments that management is working with to enhance performance, hoping they mature into the Cash Cows of tomorrow. You've got to keep an eye on the valuation adjustments made by the Valuation Committee, which considered performance and market multiples when setting the fair values for these private holdings.

The characteristics of these potential Stars include:

  • Remaining equity in high-growth sectors like cleantech and medtech, representing the Fund's core thesis.
  • The largest private holding, such as IntraOp Medical Corp., which still holds the highest relative value in the portfolio.
  • Any investment that has avoided the Q3 2025 net realized and unrealized losses of $20,083.
  • Assets that could still command a high valuation in a strategic acquisition, despite the Fund's low NAV.

The Fund's mandate is to invest at least 80% of its total assets in technology and cleantech companies, so the Stars are, by definition, central to the strategy.



Firsthand Technology Value Fund, Inc. (SVVC) - BCG Matrix: Cash Cows

You're looking at the most stable, albeit minimal, component of Firsthand Technology Value Fund, Inc.'s (SVVC) structure for the BCG Cash Cow quadrant. Honestly, for a venture capital fund focused on growth, the definition of a 'Cash Cow' is stretched thin here, but we look at what generates the most reliable, low-volatility return.

Cash and cash equivalents, the only truly stable, low-growth asset, valued at only $59,009 as of September 30, 2025. This figure represents a small fraction of the Fund's total assets of $811,382 on that date. To be fair, this cash position is the only source of stability when looking at the broader portfolio performance, which saw net realized and unrealized losses on investments of $20,083 for the third quarter of 2025.

The minimal total investment income of $2,314 reported for Q3 2025, which is the only positive cash flow component from operations before expenses. This contrasts sharply with the reported net investment loss of $430,629 for the same quarter. Here's the quick math: the total investment income was just $2,314 against total liabilities of $514,835.

Any debt instruments or preferred stock that provide a fixed, low-risk return, though this is a tiny portion of the portfolio. The portfolio summary shows Equity/Debt Investments valued at $197,925 as of September 30, 2025. Given the Fund's objective to seek long-term capital appreciation through equity and equity-related investments, any fixed-return debt component within that $197,925 is likely minimal, not characteristic of a traditional, high-yield corporate cash cow.

The Fund has no traditional Cash Cows; the cash position is the only source of stability. You can see the composition below, which clearly shows a portfolio heavily weighted toward less liquid assets, not mature, high-market-share businesses.

Portfolio Component (as of 9/30/25) Fair Value Fair Value per Share
Cash/Cash Equivalents $59,009 $0.01
Equity/Debt Investments $197,925 $0.03
Other Assets $554,448 $0.08

The overall financial picture for the period ending September 30, 2025, shows the pressure on the Fund's net assets, which stood at $296,547, down from approximately $0.7 million in Q2 2025. This context is important when considering the role of any 'Cash Cow' analogue.

  • Net Assets as of September 30, 2025: $296,547
  • Total Shares Outstanding: 6,893,056
  • Net Investment Loss for Q3 2025: $430,629
  • Total Investment Income for Q3 2025: $2,314

Still, the mandate for a Cash Cow is to 'milk' the gains passively. For Firsthand Technology Value Fund, Inc. (SVVC), the action here is maintaining that minimal cash buffer while the Valuation Committee continues its work, having adjusted fair values based on independent valuation firms during the quarter.



Firsthand Technology Value Fund, Inc. (SVVC) - BCG Matrix: Dogs

You're looking at the segment of Firsthand Technology Value Fund, Inc. (SVVC) that is struggling to generate returns, which is characteristic of the Dogs quadrant in the BCG Matrix. These are the investments that require management attention but offer little growth or cash generation potential.

The current state of the portfolio, as of September 30, 2025, strongly suggests that a significant portion of the holdings fall into this category, characterized by deep write-downs and minimal current income generation.

  • The majority of the illiquid private equity holdings that have been heavily written down.
  • Investments like Hera Systems, Inc. or Wrightspeed, Inc., which have been long-held and are now valued at a fraction of their original cost.
  • The overall portfolio value of $256,934, which is extremely low for a publicly traded VC fund.
  • Assets contributing to the Q3 2025 net investment loss of $430,629, indicating negative returns and high overhead.
  • The Fund's net assets of only $296,547, reflecting a low relative market share in the VC space.

The financial data from the third quarter ending September 30, 2025, paints a clear picture of negative operational performance for the portfolio as a whole, which is often the result of holding many Dog assets. The total investment income for the quarter was a mere $2,314, yet total net expenses reached $432,943.

Financial Metric (Q3 2025) Value
Total Investment Income $2,314
Total Net Expenses $432,943
Net Investment Loss ($430,629)
Net Realized and Unrealized Losses on Investments ($20,083)
Net Decrease In Net Assets Resulting From Operations ($450,712)

The structure of the assets as of September 30, 2025, shows that the core investments are small relative to the liabilities. The Equity/Debt Investments were valued at $197,925, which is less than the $59,009 held in Cash/Cash Equivalents. Total Liabilities stood at $514,835 against Total Assets of $811,382.

These units, which are in low growth markets and have low market share, should be avoided and minimized. Expensive turn-around plans usually do not help, and these business units are prime candidates for divestiture. The Fund reported net assets of $296,547 as of September 30, 2025, down from approximately $0.7 million as of June 30, 2025. The portfolio, including public and private securities, was valued at $256,934 on that date.



Firsthand Technology Value Fund, Inc. (SVVC) - BCG Matrix: Question Marks

You're looking at a portfolio where the core assets, by design, fit the Question Mark profile: high-growth potential markets paired with low current market share, which means they suck up cash without delivering immediate returns. The stark reality for Firsthand Technology Value Fund, Inc. (SVVC) is reflected in its third quarter 2025 performance. The Net Asset Value (NAV) per share fell to $0.04 as of September 30, 2025, down significantly from $0.11 per share at the end of Q2 2025. This drop in NAV signals that the entire business model, heavily weighted toward illiquid private technology and cleantech companies, is currently consuming capital rather than generating it.

The Fund's mandate is to invest at least 80% of its total assets in technology and cleantech companies. These are the classic Question Marks-investments in early-stage or developing firms that need massive follow-on capital to scale and capture market share. The portfolio, predominantly composed of equity and equity derivative securities of these illiquid private companies, was valued at $256,934 as of September 30, 2025. The risk here is that without successful future funding rounds or market adoption for these underlying companies, these positions risk becoming Dogs. For instance, the Fund's portfolio has included names like EQX Capital, Inc., IntraOp Medical Corp., Lyncean Technologies, Inc., UCT Coatings, Inc., and Wrightspeed, Inc., all operating in sectors where market validation is a high-stakes, cash-intensive process.

Any remaining public securities Firsthand Technology Value Fund, Inc. (SVVC) holds also fall into this quadrant, as the strategy allows investment in micro-cap public companies with market capitalizations under $250 million. These smaller public entities often exhibit high volatility because their market capitalization is low, meaning small trading volumes can cause large price swings. Still, these public holdings represent a small portion of the total value, with the total portfolio of public and private securities valued at $256,934 against total net assets of $296,547 in Q3 2025.

The Fund's stated strategy is to manage this high-risk portfolio by actively seeking exit opportunities. Honestly, this is the high-risk, high-reward bet on a near-term liquidity event that Question Marks demand. The management team is working with portfolio companies to enhance performance and uncover these exits, which is the only way to convert these high-growth bets into Stars or realize any return. The financial performance for the quarter ending September 30, 2025, shows the cost of this strategy: the Fund reported a net investment loss of $430,629 and net realized and unrealized losses on investments of $20,083. You need to see the cash burn relative to the asset base to understand the pressure.

Financial Metric (As of 9/30/2025) Value Per Share Value
Net Assets $296,547 $0.04
Total Portfolio Securities Value $256,934 $0.04
Cash/Cash Equivalents $59,009 $0.01
Total Shares Outstanding 6,893,056 N/A
Net Investment Loss (Q3 2025) $430,629 N/A
Retained Earnings (Latest Quarter) -$143.83 thousand N/A

The current situation forces a binary decision on these Question Marks, which is typical for this BCG quadrant.

  • Invest heavily to push for market share gain and Star status.
  • Divest now to stop the cash bleed and preserve remaining capital.

The Fund's low total net assets of $296,547 make the 'invest heavily' path difficult without external capital or successful exits from other positions.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.